APACC
Meeting category
Date(s)
7 Jun 2023 - 10 Jun 2023
Important dates
Regular Registration Fee Deadline
4 June 2023
Location
Singapore
Meeting type
Hybrid Meeting

APACC 2023

Related Enduring Materials

Enduring Materials
- parallel sessions

The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.

If you would like to see the program of either of the two pre-meetings, please visit their websites accordingly:

- 7 June: HIV Cascade of Care: Closing the Gap

- 8 June: Asian Stigma & Discrimination Forum 2023

Day 1 - Thursday, 8 June 2023
Plenary Session 1: Opening Session -
Chair
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
Reena Rajasuriar, MPharm, PhD
University of Malaya, Malaysia
Joseph Tucker, MD, PhD, AM
UNC Chapel Hill, United States
Welcome to the Conference
Vernon Lee, MBBS, PhD, FAMS, FAMM, MPH, MBA
Communicable Diseases Division of Singapore Ministry of Health, Singapore
Introduction - Life Time Award Prof. Praphan Phanuphak
Peter Reiss, MD, PhD
Amsterdam UMC and Amsterdam Institute for Global Health and Development, the Netherlands
Improving the Lives of People Living With and at Risk of HIV as Physician-Scientist, Visionary Leader, and Activist
Peter Reiss, MD, PhD
Amsterdam UMC and Amsterdam Institute for Global Health and Development, the Netherlands
The Role of Community Engagement in Patient Care
Rena Janamnuaysook, MBA
Institute of HIV Research and Innovation, Thailand
Reflection on the Future - What are the Next Steps to Come to Ending the Pandemic
Praphan Phanuphak, MD, PhD
Chulalongkorn University, Thailand
Discussion
Peter Reiss, MD, PhD
Amsterdam UMC and Amsterdam Institute for Global Health and Development, the Netherlands
Rena Janamnuaysook, MBA
Institute of HIV Research and Innovation, Thailand
Praphan Phanuphak, MD, PhD
Chulalongkorn University, Thailand
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
Annette Sohn, MD, PhD
TREAT Asia/amfAR, Thailand
Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc HonLLD Monash, DPMP
President and Pro Vice Chancellor, Monash University, Malaysia
Brigitte Quenum, MD, MPH
UNAIDS Asia Pacific, Thailand
Parallel Session 1: Clinical Management of HIV -
Chair
Nicholas Paton, MD, FRCP
National University of Singapore, Singapore
Junko Tanuma, MD, PhD
National Center for Global Health and Medicine, Japan
The Role of Nucleosides in Second-Line HIV Treatment
Considerations When Switching ART in People Living With HIV Who Are Virologically Suppressed
Jennifer Hoy, AM, FRACP, FAHMS
Monash University, Australia
Discussion: Role of Nucleosides in Future HIV Therapy / Can We Do Without Them?
Parallel Session 2: Abstract-Driven Session -
Chair
Thuy Le, MD, DPhil
Duke University; Oxford University Clinical Research Unit, United States / Vietnam
Fan Yang, PhD, MSc
Institute of Population Research, Peking University, China
#8 - Pay-It-Forward to Increase Testing for Hepatitis B and C Among Men Who Have Sex With Men: A Community-Led Randomized Controlled Trial in China
Ye Zhang
Australia
#9 - Incidence and Factors Associated With Hepatitis B Surface Antigen Seroclearance in HIV/HBV Coinfected Patients During Combination Antiretroviral Therapy
Yaozu He
China
#10 - In Vitro Synergy of Amphotericin B and Flucytosine Against Talaromyces Marneffei – Implications for Novel Treatment Approaches Against a Leading Aids-Associated Mycosis in Southeast Asia
Shawin Vitsupakorn
United States
#11 - The Role of a Novel TmPV1 Mycovirus on Talaromyces Marneffei Virulence and Its Impact on Human Talaromycosis Outcomes
Matt Burke
United States
Industry-Supported Satellite Symposium I -
See the full program under the "Symposia" tab
Day 2 - Friday, 9 June 2023
Capacity-Building Session 1 - Seize the Opportunity: How to Leverage Digital Tools in Sexual Health Research -
Chair:
Chunyan Li, MSc, PhD
The University of Tokyo, Japan
Virtual interventions in HIV/STI research: UNAIDS-WHO Policy Brief
Purvi Shah, MA Psychology
UNAIDS Regional Support Team Asia Pacific and WHO Global HIV Hepatitis and STI Program
Find a Doc: Using Online Crowdsourcing to Make Healthcare Services More Accessible to International Migrants
Russell Miller, MHS
University of Tokyo, Japan
HeHealth: The Potential of Artificial-Intelligence Technologies in Sexual Health Research and Practice
Expert Feedback
Junko Tanuma, MD, PhD
National Center for Global Health and Medicine, Japan
Capacity-Building Session 2 - Adapting Our Clinical Consultations for the Ageing Person Living With HIV -
Chair
Pui Li Wong, MBChB, MRCP(UK)
Universiti Malaya, Malaysia
Frailty in Older Persons Living With HIV
Grace Chung-Yan Lui, MBChB (Hons), FHKCP, FHKAM
The Chinese University of Hong Kong, Hong Kong
Clinical Scenarios on Assessing Frailty (Interactive)
Pui Li Wong, MBChB, MRCP(UK)
Universiti Malaya, Malaysia
Discussion
Reena Rajasuriar, MPharm, PhD
University of Malaya, Malaysia
Jennifer Hoy, AM, FRACP, FAHMS
Monash University, Australia
Plenary Session 2: Long-Acting ART Implementation and Policy -
Chair
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
Nagalingeswaran Kumarasamy, MD
Voluntary Health Services, Infectious Diseases Medical Centre, India
WHO Long-Acting Guidelines in Asia
Heather-Marie Schmidt, BMedSc (Hon), MPH, PhD
UNAIDS Regional Office for Asia and the Pacific, Thailand and the Global HIV, Hepatitis and STIs Programme, World Health Organisation, Switzerland
Clinical Perspective on Long-Acting ART
Stephane Wen-Wei Ku, MD
Taipei City Hospital Renai, Taiwan
Transgender Preferences Related to Long-Acting ART
Jakkrapatara Boonruang, MD
Institute of HIV and Research Innovation, Thailand
Parallel Session 3: Long-Term ARV Therapy in an Aging Population -
Chair
Reena Rajasuriar, MPharm, PhD
University of Malaya, Malaysia
Grace Chung-Yan Lui, MBChB (Hons), FHKCP, FHKAM
The Chinese University of Hong Kong, Hong Kong
Perspectives on HIV and Aging
Peter Reiss, MD, PhD
Amsterdam UMC and Amsterdam Institute for Global Health and Development, the Netherlands
Clinical Care Beyond Viral Suppression
Anchalee Avihingsanon, MD, PhD
HIV-NAT Thai Red Cross AIDS Research Centre, Thailand
Community Perspective
Thomas Tao Cai
AIDS Care China, China
Parallel Session 4: Abstract Driven Session -
Chair
Rena Janamnuaysook, MBA
Institute of HIV Research and Innovation, Thailand
Stephane Wen-Wei Ku, MD
Taipei City Hospital Renai, Taiwan
#1 - What Men Want: Preferences for Pre-exposure Prophylaxis for HIV Among Men Who Have Sex With Men in 16 Countries in the Asia-Pacific: A Discrete Choice Experiment
Warittha Tieosapjaroen
Australia
#2 - Strength in Diversity: HIV Pre-exposure Prophylaxis (PrEP) Product Interest and Preferences Among Transgender Women in 11 Countries in Asia
Nachale Boonyapisomparn
Thailand
#3 - Drug-Drug Interaction Between Emtricitabine/Tenofovir Alafenamide (FTC/TAF)-Based PrEP and Feminizing Hormones in Transgender Women: Peripheral Blood Mononuclear Cells and Urine Analysis From the iFACT3 Study
Akarin Hiransuthikul
Thailand
#4 - Drivers of Pre-exposure Prophylaxis Choice for Transgender Women in 11 Countries in Asia: A Discrete Choice Experiment
Warittha Tieosapjaroen
Australia
#5 - Mental Health and Pre-exposure Prophylaxis (PrEP) Service Integration in Vietnam: An Important Opportunity for Boosting Prep Adherence, Continuation, and Service Quality
Nga Ngo
Vietnam
#6 - “PrEP4U:” How Edutainment, Student Outreach, and Multisector Engagement Are Helping Youth in Vietnam Access HIV Prevention and Sexual Health Care
Tham Tran
Vietnam
Industry-Supported Satellite Symposium II -
See the full program under the "Symposia" tab
Guided Poster Tour -
Data-Driven HIV and Co-infection Responses
Chunyan Li, MSc, PhD
The University of Tokyo, Japan
Guided Poster Tour -
Metabolic Syndromes, Art and Comorbidities
Pui Li Wong, MBChB, MRCP(UK)
Universiti Malaya, Malaysia
Guided Poster Tour -
Community-Based and Person-Centered Research
Rodenie Arnaiz Olete, MSc, RN
National Cheng Kung University, Taiwan
Lunch & Poster Viewing
NGO Satellite Symposium I - APCOM: Shivananda Khan NGO Symposium -
Welcome to the Shivananda Khan NGO Symposium
Keynote Speaker: Overview of the HIV Epidemic in Asia and the Pacific
Heather-Marie Schmidt, BMedSc (Hon), MPH, PhD
UNAIDS Regional Office for Asia and the Pacific, Thailand and the Global HIV, Hepatitis and STIs Programme, World Health Organisation, Switzerland
Introduction of the White Paper “HIV Care Continuum & Beyond: A New Era for Asia” and Findings for Singapore
Chen Seong Wong, MBBS, MRCP(UK), FAMS
National Centre for Infectious Diseases (NCID); Tan Tock Seng Hospital, Singapore
Singaporean Community Panel
Banerjee, Sumita 2023 Circle
Sumita Banerjee
Action for AIDS, Singapore
Chua, June
June Chua
The T Project, Singapore
Tan, Alaric 2023 Circle
Alaric Tan
The Greenhouse Community Services, Singapore
Closure
NGO Satellite Symposium II - Project X: Beyond Boundaries: Transnational Issues for Sex Work in Singapore and Beyond -
Opening and Introduction
Rayner Kay Jin Tan, PhD
University of North Carolina Project-China, China
Hierarchies of Demand, Hierarchies of Safety: Mapping Inequality in Singapore's Sex Industry
Raksha mahtani, BA, Project X
Raksha Mahtani, BA
Project X, Singapore
“We are already naked”: Everyday life of Migrant Sex Workers Under the Medical Surveillance in Singapore
Mu, Rong 2023 Circle
Rong Mu, MA, MSc
Project X Singapore; Saw Swee Hock School of Public Health, National University of Singapore, China
The Case for Sex Worker Inclusion in Policy-making: Lessons from Collaborative Research with the Philippine Sex Workers Collective
Parmanand, Sharmila 2023 Circle
Sharmila Parmanand, PhD
Teaching Fellow in Gender, London School of Economics and Political Science, Philippines
Panel Discussion
Parallel Session 5: Opportunistic Infections -
Ampho-terrible – Less is More for AIDS-Associated Mycoses
Thuy Le, MD, DPhil
Duke University; Oxford University Clinical Research Unit, United States / Vietnam
How to Reduce OIs and AIDS Deaths in Southeast Asia from the WHO
Nathan Ford, MPH, PhD, FRCPE
World Health Organization, Switzerland
Discussion: Access to Medications and Diagnostics for Advanced HIV in the Asia Pacific
Parallel Session 6: Abstract-Driven Session -
Chair
Pui Li Wong, MBChB, MRCP(UK)
Universiti Malaya, Malaysia
Purvi Shah, MA Psychology
UNAIDS Regional Support Team Asia Pacific and WHO Global HIV Hepatitis and STI Program
#12 - Disability in PLWH in Asia: A Prospective Multi-Centre Case-Control Study
Grace Lui
Hong Kong
#13 - Association Between Non-alcohol Steatohepatitis With Significant Activity and Fibrosis and Neurocognitive Impairment and Cardiovascular Disease Risk in HIV
Win Min Han
Australia
#14 - Frailty Transition Among Older Adults Living With HIV in Thailand: A Five-Year Prospective Cohort Study
Tanakorn Apornpong
Thailand
#15 - Measuring Intrinsic Capacity: A Screening Tool for Integrated Care in Ageing People Living With HIVmeasuring Intrinsic Capacity: A Screening Tool for Integrated Care in Ageing People Living With HIV
Reena Rajasuriar
Malaysia
#16 - Significant Blood Glucose Changes and Incidence of New-Onset Diabetes Mellitus in Thai People Living With HIV Receiving Dolutegravir
Thornthun Ueaphongsukkit
Thailand
Debate: PrEP Should Be Made Available Without a Prescription in the Asia Pacific Region -
Moderator
Annette Sohn, MD, PhD
TREAT Asia/amfAR, Thailand
Pro Standpoint
Con Standpoint
Chen Seong Wong, MBBS, MRCP(UK), FAMS
National Centre for Infectious Diseases (NCID); Tan Tock Seng Hospital, Singapore
Industry-Supported Satellite Symposium -
See the full program under the "Symposia" tab
NGO Symposium III - SESH Global: Crowdsourcing Solutions From the Community to End HIV in East Asia -
Aims and Activities of the HOPE Network
Jason Ong 2023
Jason Ong, PhD, MMed, MBBS, FAChSHM, FRACGP
Monash University / London School of Hygiene and Tropical Medicine, Australia
How Communities were Engaged to Provide Solutions to Improve PrEP Awareness and Uptake Using Crowdsourcing – Experience from Philippines and Australia
Ongkeko Jr, Arturo M 2023
Arturo M. Ongkeko Jr., RN, MSc
National Institutes of Health, University of the Philippines Manila, the Philippines
Tieosapjaroen, Warittha 2023
Warittha Tieosapjaroen, PharmD, MBiotech
Central Clinical School, Monash University, Australia
Panel Discussion: How to Better Involve End-users in the Design of HIV Prevention Methods in Asia
Weiming Tang, PhD, MD, MS
University of North Carolina Project-China, China
Joseph Tucker, MD, PhD, AM
UNC Chapel Hill, United States
Castillo-Carandang, Nina T. 2023
Nina T. Castillo-Carandang, PhD, MS
University of the Philippines Manila, the Philippines
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
NGO Symposium IV - Taiwan HIV Story Association: HIV is Not the Restrict of Life -
Current Status of HIV/AIDS Treatment, Stigma, and Discrimination in Taiwan
Yang, Cheng-Xun 2023 Circle
Cheng-Xun Yang, MD
Kaohsiung Chang Gung Memorial Hospital, Taiwan
Empowerment and Social Engagement Experience of People Living with HIV/AIDS in Taiwan
Wang, Chia-Ching (Raymond) 2023 Circle
Chia-Ching (Raymond) Wang, M.Ed., CSW, CCP
Taiwan HIV Story Association, Taiwan
Discussing the Countermeasures to the Current Situation of AIDS Discrimination in Various Countries (Open to the Attendees)
Feng, Yi-Fang 2023 Circle
Yi-Fan (Miguel) Feng
Harmony Home Taiwan; Taiwan HIV Story Association, Taiwan
Day 3 - Saturday, 10 June 2023
Capacity Building 3 - Community-Based Research to Improve HIV Care: Tools, Frameworks, and Language -
Chair:
Rodenie Arnaiz Olete, MSc, RN
National Cheng Kung University, Taiwan
Nai-Ying Monica Ko, RN, PhD
National Cheng Kung University, Taiwan
The Importance of Community-Based Approach in HIV Research
Rodenie Arnaiz Olete, MSc, RN
National Cheng Kung University, Taiwan
Application of Community-Based Research Models in the Biomedical Science
Rayner Kay Jin Tan, PhD
University of North Carolina Project-China, China
Translating HIV Evidence into Community Language
Benjamin Bavinton, PhD, MPH
The Kirby Institute, University of New South Wales, Australia
More than a Research Sample: A Call for Deeper Collaborations between Researchers and the Community
Inad Quiñones Rendon
APCOM, Thailand
Discussion
Rodenie Arnaiz Olete, MSc, RN
National Cheng Kung University, Taiwan
Rayner Kay Jin Tan, PhD
University of North Carolina Project-China, China
Inad Quiñones Rendon
APCOM, Thailand
Benjamin Bavinton, PhD, MPH
The Kirby Institute, University of New South Wales, Australia
Parallel Session 7: Implementation Science -
Chair
Joseph Tucker, MD, PhD, AM
UNC Chapel Hill, United States
Rayner Kay Jin Tan, PhD
University of North Carolina Project-China, China
Pay-It-Forward HPV Vaccination: A Cost-Effectiveness Analysis
Dan Wu, PhD, MSc, MBBS
London School of Hygiene and Tropical Medicine, China
Use Implementation Science to promote best practices in HIV/AIDS Care
Dong (Roman) Xu, PhD, MPP
Southern Medical University (SMU), China
Demedicalizing Long-Acting PrEP/ART
Rupa Patel, MD, MPH
Washington University School of Medicine, United States
Parallel Session 8: HBV and HPV : The Intersection of Infectious Diseases and Cancer -
Chair
Thana Khawcharoenporn, MD, MSc
Thammasat University, Thailand
Jason Ong, PhD, MMed(Hons), MBBS, FAChSHM, FRACGP
Monash University / London School of Hygiene and Tropical Medicine / University of Melbourne, Australia
Paving the Way to HBV Elimination with Old Stones - Vaccines and PrEP
Yi-Chia Huang, MD
National Taiwan University Hospital Hsin-Chu Branch, Taiwan
On the Pathway to HBV Cure: Challenges and Successes
Seng Gee Lim, FRACP, FRCP, FAMS, MD
National University Hospital, Singapore
HPV, HIV, and Anal Cancer Prevention
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
HPV, HIV, and Cervical Cancer Prevention
Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc HonLLD Monash, DPMP
President and Pro Vice Chancellor, Monash University, Malaysia
Abstract Driven Session: Late Breaker -
#LB_1 - Interaction Between Masculinizing Hormone Therapy and Daily Oral F/TDF and F/TAF PrEP in Transgender Men: Analysis of Testosterone Concentrations From the iMACTStudy
Akarin Hiransuthikul
Thailand
#LB_2 - Evaluation of a Multilingual HIV and Syphilis Testing Project for International Migrants in Tokyo, Japan
Tsutomu Kitajima
Japan
#LB_3 - Differentiated HIV Services for Key Populations: The New Initiatives by NGO in Delivery HIV Self-Testing and Other Support Services in Malaysia via the JOM TEST Programme a.k.a JOM TEST
Davindren Tharmalingam
Malaysia
Plenary Session 9: Management of Tuberculosis -
Chairs
Joseph Tucker, MD, PhD, AM
UNC Chapel Hill, United States
Saye Khoo, MD, PhD
Royal Liverpool University Hospital; University of Liverpool, United Kingdom
Drug Resistant Tuberculosis - Is the Era of Personalised Cocktails Over and Do We Now Have a Single Preferred Regimen?
Erlina Burhan, MD, MSc, PhD
Faculty of Medicine Universitas Indonesia; Persahabatan National Respiratory Referral Hospital, Indonesia
Drug Susceptible Tuberculosis - Is a 2-Month Treatment Regimen Possible?
Nicholas Paton, MD, FRCP
National University of Singapore, Singapore
Extrapulmonary Tuberculosis
Guy Thwaites, MBE, MA, MBBS, PhD, FRCP, FRCPath, FMedSci
Oxford University Clinical Research Unit (OUCRU) and Wellcome Africa Asia Programme, Vietnam
Plenary Session 10: Management of Long COVID-19 -
Chairs
Chen Seong Wong, MBBS, MRCP(UK), FAMS
National Centre for Infectious Diseases (NCID); Tan Tock Seng Hospital, Singapore
Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc HonLLD Monash, DPMP
President and Pro Vice Chancellor, Monash University, Malaysia
Preventing Death, Hospitalization, and Long COVID-19 – New Evidence from Clinical Trial Data
David Boulware, MD, MPH, CTropMed, FIDSA
University of Minnesota, United States
Characteristics of Hospitalized COVID-19 Patients in Japan: The Insights From COVID-19 Registry Japan
Kayoko Hayakawa, MD, PhD
National Center for Global Health and Medicine, Japan
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Barnaby Edward Young, MB BChir, PhD
National Centre for Infectious Diseases (NCID), Singapore
Closure of APACC 2023 -
Closing Words
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
Reena Rajasuriar, MPharm, PhD
University of Malaya, Malaysia
Joseph Tucker, MD, PhD, AM
UNC Chapel Hill, United States
Symposia
Thursday, 8 June 2023
Industry Supported Symposium - ViiV Healthcare: Individualized Care for People Living with HIV -
Welcome & Opening
Gatell, Jose 2023
Jose Gatell, MD, PhD
ViiV Healthcare, Spain
HIV Care Is Individual Care
Adeeba Kamarulzaman
Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc HonLLD Monash, DPMP
President and Pro Vice Chancellor, Monash University, Malaysia
Improving HIV Care with Early Optimization
Gatell, Jose 2023
Jose Gatell, MD, PhD
ViiV Healthcare, Spain
Evidence Into Practice
Eu, Beng 2023
Beng Eu, MBBS
Prahran Market Clinic, Australia
Chien-Yu Cheng 2023
Chien-Yu Cheng, MD
Taoyuan General Hospital, Taiwan

In this ViiV-supported symposium, an international expert faculty will discuss why individualizing care for PLHIV is so important, and how this can best be achieved.

Prof. Adeeba Kamarulzaman will introduce the importance of individualized HIV care and highlight the recent findings of patient-reported outcomes. Prof. Jose Gatell will review data from clinical trials, demonstrating the potential of 2-drug and long-acting treatment options, and how these help to optimize patient care. Dr. Chien-Yu Cheng and Dr. Beng Eu will share their personal experiences, and the importance of real-world evidence, to inform clinical decision-making and the personalization of treatment for patients.

The session will conclude with a panel discussion and an opportunity for live Q&A with the experts.

Friday, 9 June 2023
Industry Supported Symposium - ViiV Healthcare: Past, Present, Future of Holistic Patient Care -
Welcome
Mark Nelson
Mark Nelson, MA, MBBS, FRCP
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Overview of ARV Development & HIV Management Roadmap in the Past 3 Decades - What Needs to Change?
Mark Nelson
Mark Nelson, MA, MBBS, FRCP
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Praphan Phanuphak
Praphan Phanuphak, MD, PhD
Chulalongkorn University, Thailand
An Asian Case Study - What Does Individualized Treatment Mean to Me?
Yee, Choy Chiaw 2023
Choy Chiaw Yee, MBBS, MRCP
Singapore National Centre of Infectious Diseases (NCID), Singapore
Peng, Ho Lai 2023
Ho Lai Peng, PhD
Singapore National Centre for Infectious Diseases (NCID), Tan Tock Seng Hospital (TTSH), Singapore
Summary
Mark Nelson
Mark Nelson, MA, MBBS, FRCP
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom

In this ViiV-supported medical symposium, an international expert faculty shared their own clinical experiences to discuss the past, present and future of HIV care.

Prof. Mark Nelson led a discussion with Prof. Praphan Phanuphak to shed light on the history of HIV/AIDS in Asia. They focused on the evolution of ART and holistic HIV care over the past four decades. Looking ahead, they then explored the potential evolution of Modern ART, discussing the necessary changes to optimize HIV care in the next 30 years. 

Dr. Choy Chiaw Yee and Dr. Lai Peng Ho both discussed the History of ART, sharing case studies from Asia and demonstrating how data influenced clinical decisions. 

Prof. Mark Nelson then concluded reflecting what makes a Modern Masterpiece.

Industry Supported Symposium - Gilead: Leaving No One Behind – Closing the 3rd 90 Gap in Asia -
Opening
Wong, Tin Hung 2023
Tin Hung Wong, MBBS. (Hong Kong)
Gilead Sciences, Hong Kong
Significance and Clinical Management of Persistent Low-Level Viremia
Seong, Wong Chen 2023
Chen Seong Wong, MBBS. (SING), MRCP(UK), FAMS
National HIV Programme / NCID HIV Clinical Programme / National Centre for Infectious Diseases / Tan Tock Seng Hospital, Singapore
Role of Modern ART in Managing Heavily Treatment-Experienced PLWH
Hung, Chien-Ching 2023
Chien-Ching Hung, MD, PhD
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan

The Gilead Sciences-sponsored symposium at APACC this year was themed ‘Leaving No One Behind – Closing the 3rd 90 Gap in Asia’ and aimed to provide a platform for healthcare professionals to discuss the latest clinical updates, real-world challenges, and strategies to optimize treatment outcomes in the management of people living with HIV (PLWH) across the Asia Pacific region. Specifically, the objectives of this session were to:

  • Review the complex challenges of managing PLWH in Asia

  • Discuss strategies to bridge the current treatment gaps in Asia 

  • Explore the clinical significance of persistent low-level viremia and the role of modern ART in managing heavily treatment-experienced PLWH

NGO Symposium
NGO Symposium Opportunities Available

Are you an NGO specializing in HIV and co-infections active in the Asia-Pacific region?

Good news!

We are delighted to offer exclusive symposium opportunities for APACC 2023! Take advantage of the opportunity to connect with key opinion leaders, organizations, and clinicians and get in touch with the organizing secretariat to secure a slot for your organization.

NGO Symposium Slot

The deadline for the NGO Symposium Slot has passed.

Deadline for Application: Friday, March 31, 2023, 23:59 SGT

Requirements:

1) Proposal must be submitted by an NGO

2) Proposal submission by the deadline at the latest. There will be running approvals, so please submit any proposals at your earliest convenience to improve your changes of approval.

3) Proposal must be

  • Maximum 2 pages
  • In English
  • Include:

- Title;

- Purpose;

- Target audience;

- Summary of content (including if any special set-up will be needed);

- Potential / confirmed speakers; and

- Learning objectives.

Selection Process
  • Applications will be reviewed by the Program Chairs and Scientific Management.
  • Preference will be given to applications with relevance for the Asia-Pacific region.
  • There are limited slots available and these will be divided on a “first-come-first-served” basis. Applications will be reviewed on a regular basis with running approval and allocation of time/date slot. Therefore, the sooner you submit an application, the better are the chances of the application being approved and included in the program.
Overview
Welcome

Dear colleagues,

The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2023 took place from 8 to 10 June 2023 at the Suntec Singapore Convention & Exhibition Centre as a hybrid conference. 

Over the years, enormous progress has been made in the fight against HIV and co-infections. Both academia and industry have contributed greatly to equipping the medical community with the best medications and expertise possible to optimally treat people living with HIV. However, international platforms for scientific interchange are not always accessible to medical professionals worldwide due to budget and travel restrictions. Also, most major conferences do not usually address local and regional issues. In particular, the Asian medical community in this field of research currently has very few platforms that serve the needs of HIV healthcare professionals in this region.

APACC provides a much-needed scientific platform that focuses on the developments, issues, and needs in the Asia-Pacific region. Researchers have the opportunity to present and discuss the latest developments and are offered opportunities for interaction, networking, and building collaborations. Top experts integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round table discussions, and debates in order to reach a consensus on best practices and inform how treatment guidelines are implemented.

Nittaya Phanuphak, Reena Rajasuriar, and Joseph Tucker.

Co-chairs, APACC 2023

Program Chairs 2023
General Information 
COVID-19 Entry Requirements
Travellers seeking to enter Singapore should comply with the prevailing Public Health as well as Entry Requirements, including all COVID-19-related requirements. You can find more information here: https://www.ica.gov.sg/enter-transit-depart/entering-singaporea
Who Should Attend?
- Residents, post-graduates, and PhD students;

- Government agency personnel, NGO representatives, and health authority personnel;

- Industry representatives;

- Social workers, advocates, and community workers;

- Other healthcare professionals involved in treating HIV and co-infected patients.
Meeting Objectives
This meeting aims to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients;

- Create a platform for interactive information exchange on novel treatment strategies and options;

- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV.
Learning Objectives
After participating in this meeting, participants will be able to:

- Describe the similarities and differences between the different international/ regional treatment guidelines;

- Select optimal treatment strategies for their patients understanding the various clinical parameters affecting the choice of regimens;

- Recall to latest developments for HIV prevention;

- Discuss the suitability of oral versus intramuscular injections for prevention/treatment;

- Summarize and compare the options for starting antiretroviral treatment;

- Describe the concept of early diagnosis and rapid start;

- Review the treatment options for patients failing on their current regimen.
Practical Information 
Venue
The APACC 2023 will be taken place at Suntec Singapore Convention & Exhibition Centre (1 Raffles Boulevard Singapore 039593).
Entry Requirements
All travelers arriving to Singapore, are required to possess a valid travel document to entry Singapore. To find out which one applies to you, please visit the Singapore Government Agency Website: https://www.ica.gov.sg/enter-transit-depart/entering-singapore/visa_requirements

Other requirements: https://www.ica.gov.sg/enter-transit-depart/entering-singapore
Accommodation
As you plan your trip to Singapore, we want to make your stay as comfortable and convenient as possible. Therefore, we have secured a list of appropriate hotels with beneficial rates in the area.

Under the Accomodation-tab on this website, you can find a variety of room and price categories in different hotels to accommodate your stay for APACC 2023.



- Accommodation is not included in the registration fee.
Badges
All participants are requested to wear their badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
- A Certificate of Attendance will be sent to participants after successfully completing the program and post-meeting survey.
Enduring Materials
Conference materials can be obtained upon registration at the registration desk at the Conference Venue.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Committees
Program Chairs 2023
Organizing Committee
Scientific Committee
Hung, Chien-Ching 2023
Chien-Ching Hung, MD, PhD
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
APACC Fellows (2023-2024)
The purpose of the APACC Fellows Program is to provide early-career investigators with an opportunity to learn about HIV and co-infection research, conference organization, and leadership through serving on the Organizing Committee of APACC. Fellows will help to develop conference session content for other early-career investigators and promote APACC over a two-year term. The Organizing Committee is responsible for the overall content of the conference program, driving conference engagement, and selecting abstracts and panel topics. Fellows will receive support to attend the conference for each of the two years in which they participate (remotely or in-person, as appropriate). 
Support
Platinum Level
Bronze Level
Friend Level
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in HIV and co-infections with HIV.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause and get in touch with us for a tailored support package, please contact Rikke Puggaard-Rode at rikke.rode@amededu.com or call +31 30 230 7142.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgement during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgement on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level.

Endorsers

APACC 2023 is endorsed by the following societies and organizations. Their support and collaboration are key to the success of this program!

If you would like your organization to endorse this meeting, please contact Andrés (Yuxuan) Ma at yuxuan.ma@amededu.com.

Endorsers
Previous Editions
Accreditation

APACC 2023 is accredited by the following societies. To claim the CME points, members of the societies must either log on to the virtual congress portal, or sign up on the attendance sheet onsite, and attend the full sessions. Additional information such as membership number or license number might be required after the event.

Taiwan AIDS Society
Taiwan AIDS Society

APACC 2023 is accredited by the Taiwan AIDS Society with 4 credits. To claim the CME points, members of the Taiwan AIDS Society must log on to the virtual congress portal or sign up on the attendance sheet onsite and attend the full sessions.  

Hong Kong Academy of Medicine (HKAM)

Fellows of the Academy that participate in overseas activities physically or online may submit their attendance proofs to their respective Colleges for CMECPD claim. Please be aware that some Academy Colleges might request their Fellows to seek pre-approval before attending overseas CMECPD activities. The approval will be up to individual Colleges’ own CMECPD accreditation policies

European Accreditation Council for Continuing Medical Education (EACCME)
EACCME

The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2023, Singapore, 08/06/2023 - 10/06/2023, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 11 European CME credits (ECMEC®s). Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Infectious Diseases Association of Thailand (IDAT)
Infectious Disease Association of Thailand

APACC 2023 is accredited by the Infectious Diseases Association of Thailand (IDAT) with up to 14.5 credits. To claim the CME points, members of the IDAT must attend the full sessions (in-person or virtually). 

   8 June 

    9 June 

    10 June 

      4.75

 CME Points  

       4.75

  CME Points

         5

CME Points

Malaysian Pharmacists Society

APACC 2023 is accredited by the Malaysian Pharmacists Society with 20 credits. To claim the points, members must attend the full sessions (in-person or virtually). 

Language
Ratings previous edition
Overall event experience
4.5
(130)
Content is relevant to my practice
4.4
(130)
Content was presented clearly
4.5
(130)
Content was free from commercial bias
4.3
(130)
I would recommend APACC to my peers
5.0
(130)